声触诊弹性成像在非酒精性脂肪性肝病合并慢性乙型肝炎诊断中的应用价值

doi:10.19871/j.cnki.xfcrbzz.2024.04.006

新发传染病电子杂志 ›› 2024, Vol. 9 ›› Issue (4): 29-33.doi: 10.19871/j.cnki.xfcrbzz.2024.04.006

声触诊弹性成像在非酒精性脂肪性肝病合并慢性乙型肝炎诊断中的应用价值

李晓慧¹, 曾伟梅¹, 董常峰¹, 郑保奇¹, 陈昕², 刘忠²

1.深圳市第三人民医院超声科,广东深圳 518112;
2.深圳大学生物医学工程学院,广东深圳 518000

收稿日期:2024-02-02 出版日期:2024-08-31 发布日期:2024-10-10
通讯作者: 郑保奇,Email: 415625448@qq.com
基金资助:
国家自然科学基金重大科研仪器研制项目（82327804）; 深圳市第三人民医院院内项目（G2022018）

Application value of sound touch elastography in diagnosing nonalcoholic fatty liver disease complicated with chronic hepatitis B

Li Xiaohui¹, Zeng Weimei¹, Dong Changfeng¹, Zheng Baoqi¹, Chen Xin², Liu Zhong²

1. Department of Ultrasound, Shenzhen Third People's Hospital, Guangdong Shenzhen 518112, China;
2. School of Biomedical Engineering, Shenzhen University, Guangdong Shenzhen 518000, China

Received:2024-02-02 Online:2024-08-31 Published:2024-10-10

摘要/Abstract

摘要： 目的探讨声触诊弹性成像（sound touch elastography,STE）诊断非酒精性脂肪性肝病（non-alcoholic fatty liver disease,NAFLD）合并慢性乙型肝炎（chronic hepatitis B,CHB）的价值,明确STE分期诊断NAFLD合并CHB患者肝纤维化程度的效能。方法选取2018年1月至2023年1月在深圳市第三人民医院肝病科就诊的NAFLD患者74例和NAFLD合并CHB患者142例,分别纳入NAFLD组、NAFLD合并CHB组。选取健康志愿者61例,纳入对照组。NAFLD合并CHB组患者根据METAVIR肝纤维化分级标准分为S1期、S2期、S3期、S4期。所有受试者均接受肝STE、肝声触诊定量（sound touch quantify,STQ）检查,比较三组间肝弹性测值有无差异,绘制受试者操作特征曲线（receiver operator characteristic curve,ROC曲线）。结果三组间肝硬度值（liver stiffness measurement,LSM）、肝STE、肝STQ有统计学差异（P<0.001）。肝STE、肝STQ区分对照组与NAFLD合并CHB组的ROC曲线下面积（under the curve,AUC）为0.834、0.805;区分对照组与NAFLD组的AUC为0.628、0.617;区分NAFLD合并CHB组与NAFLD组的AUC为0.741、0.715。肝STE诊断NAFLD合并CHB组≥S1、≥S2、≥S3期肝纤维化和S4期肝硬化的AUC分别为0.834、0.889、0.940、0.950。结论 NAFLD合并CHB时,肝脏STE、STQ值较NAFLD患者及正常人群升高。肝STE在分期诊断NAFLD合并CHB患者肝纤维化程度方面具备显著价值。

关键词: 非酒精性脂肪性肝病, 慢性乙型肝炎, 声触诊弹性成像, 声触诊定量

Abstract: Objective To explore the value of sound touch elastography(STE) in diagnosing non-alcoholic fatty liver disease (NAFLD) complicated with chronic hepatitis B (CHB) and identifying the Diagnostic efficacy of STE for staging the degree of liver fibrosis in this combination. Method A total of 74 NAFLD patients and 142 NAFLD patients complicated with CHB who were selected from January 2018 to January 2023 were included in the NAFLD group and NAFLD complicated with CHB group, respectively. NAFLD complicated with CHB group were classified as stage S1, stage S2, stage S3, and stage S4 according to the METAVIR grading criteria. 61 healthy volunteers were selected and included in the control group. All subjects accepted liver STE and liver STQ examinations. Compare the three groups and draw the receiver operator characteristic curve (ROC). Result There was significant difference in liver STE and liver STQ among the three groups (P<0.001). The area under the curve (AUC) of liver STE and liver STQ between control group and NAFLD complicated with CHB group was 0.834 and 0.805, the AUC between control group and NAFLD group was 0.628 and 0.617, and the AUC between NAFLD complicated with CHB group and NAFLD group was 0.741 and 0.715. The AUC of liver STE in diagnosing NAFLD complicated with CHB ≥S1, ≥S2, ≥S3 liver fibrosis and S4 cirrhosis were 0.834, 0.889, 0.940, 0.950 respectively. Conclusion There were differences in liver stiffness measurement (LSM) among NAFLD complicated with CHB, NAFLD and normal liver. Liver STE can distinguish NAFLD complicated with CHB Group from control group and NAFLD group, it has great value in the diagnosis of liver fibrosis in patients suffered NAFLD complicated with CHB.

Key words: Non-alcoholic fatty liver disease, Chronic hepatitis B, Sound touch elastography, Sound touch quantify

中图分类号:

R512.91

李晓慧, 曾伟梅, 董常峰, 郑保奇, 陈昕, 刘忠. 声触诊弹性成像在非酒精性脂肪性肝病合并慢性乙型肝炎诊断中的应用价值[J]. 新发传染病电子杂志, 2024, 9(4): 29-33.

Li Xiaohui, Zeng Weimei, Dong Changfeng, Zheng Baoqi, Chen Xin, Liu Zhong. Application value of sound touch elastography in diagnosing nonalcoholic fatty liver disease complicated with chronic hepatitis B[J]. Electronic Journal of Emerging Infectious Diseases, 2024, 9(4): 29-33.

参考文献

[1] CHOI H, BROUWER WP, ZANJIR W, et al.Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B[J]. Hepatology, 2020, 71(2):539-548.
[2] PELEG N, ISSACHAR A, SNEH AO, et al.Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load[J]. JHEP Rep, 2019, 1(1):9-16.
[3] LEE YB, HA Y, CHON YE, et al.Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B[J]. Clin Mol Hepatol, 2019,25(1):52-64.
[4] 李玉丹,董常峰. 声辐射脉冲成像技术与谷草转氨酶/血小板指数诊断非酒精性脂肪性肝病肝纤维化的比较[J/CD]. 中华医学超声杂志(电子版), 2017, 14(7):544-548.
[5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版)[J]. 中华肝脏病杂志, 2018, 26(3):195-203.
[6] FISCHER HP, WILLSCH E, BIERHOFF E, et al.An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group[J]. Hepatology, 1996, 24(2):289-293.
[7] ZHANG YN, FOWLER KJ, OZTURK A, et al.Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography[J]. J Magn Reson Imaging, 2020, 51(1):25-42.
[8] TAN CH, VENKATESH SK.Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions[J]. Gut Liver, 2016, 10(5):672-686.
[9] TAMAKI N, KUROSAKI M, HUANG DQ, et al.Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease[J]. Hepatol Res, 2022, 52(6):497-507.
[10] WANG L, ZHU M, CAO L.Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study[J]. J Clin Transl Hepatol, 2019, 7(4):313-321.
[11] 李沁园,董常峰,姜伟.超声弹性成像对肝纤维化的诊断及应用[J/CD].新发传染病电子杂志,2020,5(3):207-211
[12] CHOI HSJ, BROUWER WP, ZANJIR WMR, et al.Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B[J]. Hepatology, 2020, 71(2): 539-548.
[13] GUO Y, LIN H, DONG C, et al.Role of acoustic radiation force impulse imaging elastography in the assessment of steatohepatitis and fibrosis in rat models[J]. Medical engineering & physics, 2018, 59: 30-35.
[14] PAROLA M, PINZANI M.Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues[J]. Mol Aspects Med, 2019, 65:37-55.
[15] OZTURK A, OLSON MC, SAMIR AE, et al.Liver fibrosis assessment: MR and US elastography[J]. Abdom Radiol (NY), 2022, 47(9):3037-3050.

声触诊弹性成像在非酒精性脂肪性肝病合并慢性乙型肝炎诊断中的应用价值

Application value of sound touch elastography in diagnosing nonalcoholic fatty liver disease complicated with chronic hepatitis B

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

本文评价

[1]	古晓利, 潘秋合, 陈建波, 郭青. 双能量CT增强与磁共振弹性成像联合诊断慢性乙型肝炎肝纤维化的临床价值[J]. 新发传染病电子杂志, 2024, 9(3): 56-60.
[2]	董旭, 刘亚允, 朱彤, 徐爱静, 薛建亚, 梁雪松. 基于HBV感染自然病程的慢性乙型肝炎患者外周血白细胞介素-35表达水平及与病毒载量和转氨酶的相关性[J]. 新发传染病电子杂志, 2023, 8(2): 8-12.
[3]	王莲珊, 马雪梅, 郑成芳. 重度慢性乙型肝炎患者外周血单个核细胞中焦亡相关因子表达及与预后的关系[J]. 新发传染病电子杂志, 2023, 8(2): 28-33.
[4]	罗杰, 杜展, 豆小文, 李俭, 陈明发, 李曼妮, 尹燕耀. 聚乙二醇干扰素α治疗非活动性HBsAg携带者的疗效[J]. 新发传染病电子杂志, 2023, 8(2): 53-57.
[5]	王宏霞, 王艳, 段瑞娴, 张建伟, 任圆. 代谢综合征及其组分对慢性乙型肝炎患者血清HBsAg水平的影响[J]. 新发传染病电子杂志, 2023, 8(1): 31-34.
[6]	李延东, 范荣山. 谷丙转氨酶持续正常的慢性乙型肝炎病毒感染者肝脏病理特征及预测因素[J]. 新发传染病电子杂志, 2023, 8(1): 44-47.
[7]	刘星, 吴威, 张晓明, 李强, 权冬梅, 张朕, 戴越, 张麟格, 宋冠男, 李欣悦, 朱一丹, 王岩. 非酒精性脂肪性肝病及原发性肝细胞癌患者接种新型冠状病毒灭活疫苗的安全性及免疫原性[J]. 新发传染病电子杂志, 2022, 7(3): 50-54.
[8]	黄秀玲, 冯程, 董常峰. 超声新技术诊断慢性乙型病毒性肝炎合并非酒精性脂肪性肝病新进展[J]. 新发传染病电子杂志, 2022, 7(2): 95-98.
[9]	丁霞, 廖桂婵, 夏牧晔, 彭劼. 探讨长期核苷（酸）类药物治疗慢性乙型肝炎患者停药后复发的影响因素[J]. 新发传染病电子杂志, 2019, 4(1): 52-57.
[10]	蓝云翠, 刘曦, 丁立, 周耀勇, 夏瑾瑜. 611例CHB患者的临床指标与肝脏组织学关系研究[J]. 新发传染病电子杂志, 2017, 2(2): 72-75.